With regional differences in which name is used for the aortic fix, some say unity is needed. Others can live with both.

CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life ...

The study, published in the European Heart Journal, used data from the Australian Burden of Disease Database on illness caused by heart disease from 2003 to 2018. “When the weather is hot ...

There is a considerable gap when it comes to our understanding of the role that exercise plays before a patient with heart failure is hospitalized. Now, in a recent study published in the European ...

Today is World Oral Health Day (March 20), so it's the perfect time to talk about the importance of good oral hygiene and its ...

The study, published in the European Journal of Preventive Cardiology, showed SGLT2 inhibitors can lower the risk of heart failure and unplanned hospital visits related to heart failure by more ...

Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure Outcomes in Cancer Patients and Survivors: A Systematic Review and Meta-Analysis, European Journal of Preventive Cardiology (2025).

Sequana Medical announces 2024 Full Year Results and 2025 Outlook alfapump® - US FDA approval of alfapump® for the treatment of recurrent or refractory ascites due to liver cirrhosis; US commercial ...

Reassurance was the theme at the China Development Forum in a sign that Beijing seeks to offset trade pressures rather than ...

On 3 April 2024, the Company announced publication of the results of the RED DESERT and SAHARA proof-of-concept studies, in the prestigious peer-reviewed journal European Journal of Heart Failure.

‘Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure Outcomes in Cancer Patients and Survivors: A Systematic Review and Meta-Analysis' is published in the European Journal of ...